retatrutide first week π¨The phase 3 trial, TRIUMPH-4, top-line data announced today π¨ π Retatrutide, a triple GLP-1,GIP, glucagon agonist studied in patients with obesity and osteoarthritis π 28.7% weight loss at 68 Retatrutide Shows 28% Weight Loss
Pay in 4 interest-free payments of $6.15 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Jul 31 - Aug 5




:max_bytes(150000):strip_icc()/insulin-injection-478185779-594b3cae3df78cae8111498f.jpg)





















